101 related articles for article (PubMed ID: 22505565)
41. Macroprolactin and hyperprolactinaemia.
Wiwanitkit V
Malays J Pathol; 2013 Dec; 35(2):189. PubMed ID: 24362486
[No Abstract] [Full Text] [Related]
42. The natural history of macroprolactinaemia.
Hattori N; Adachi T; Ishihara T; Shimatsu A
Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016
[TBL] [Abstract][Full Text] [Related]
43. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
Jeske W; Zgliczynski W; Zdunowski P
J Clin Endocrinol Metab; 2002 Apr; 87(4):1909-10; author reply 1910. PubMed ID: 11932344
[No Abstract] [Full Text] [Related]
44. Thermal degradation of polyethylene glycol 6000 and its effect on the assay of macroprolactin.
Boughen L; Liggat J; Ellis G
Clin Biochem; 2010 Jun; 43(9):750-3. PubMed ID: 20303933
[TBL] [Abstract][Full Text] [Related]
45. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.
Smith TP; Suliman AM; Fahie-Wilson MN; McKenna TJ
J Clin Endocrinol Metab; 2002 Dec; 87(12):5410-5. PubMed ID: 12466327
[TBL] [Abstract][Full Text] [Related]
46. [Heterogeneity of immunoreactive prolactin in hyperprolactinemia of various origin].
Bulatov AA; Makarovskaia EE; Dzeranova LK; Smirnova NB; Chernogolov VA; Marova EI; Mel'nichenko GA; Dedov II
Probl Endokrinol (Mosk); 1992; 38(6):13-6. PubMed ID: 1302839
[TBL] [Abstract][Full Text] [Related]
47. Rapid detection of macroprolactin in the form of prolactin-immunoglobulin G complexes by immunoprecipitation with anti-human IgG-agarose.
Schiettecatte J; De Schepper J; Velkeniers B; Smitz J; Van Steirteghem A
Clin Chem Lab Med; 2001 Dec; 39(12):1244-8. PubMed ID: 11798085
[TBL] [Abstract][Full Text] [Related]
48. Reactivity of macroprolactin in common automated immunoassays.
Schneider W; Marcovitz S; Al-Shammari S; Yago S; Chevalier S
Clin Biochem; 2001 Sep; 34(6):469-73. PubMed ID: 11676976
[TBL] [Abstract][Full Text] [Related]
49. Reporting of post-PEG prolactin concentrations: time to change.
Smith TP; Fahie-Wilson MN
Clin Chem; 2010 Mar; 56(3):484-5. PubMed ID: 19959619
[No Abstract] [Full Text] [Related]
50. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
Hattori N; Ishihara T; Saiki Y
Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
[TBL] [Abstract][Full Text] [Related]
51. [Use of a new protocol for prolactin extraction and reduction of false hyperprolactinemia].
Robles Rodríguez JL; Castaño López MA
Endocrinol Nutr; 2010; 57(7):296-300. PubMed ID: 20542746
[TBL] [Abstract][Full Text] [Related]
52. Effect of hemolysis on insulin determination by the Beckman Coulter Unicell DXI 800 immunoassay analyzer.
Cook PR; Glenn C; Armston A
Clin Biochem; 2010 Apr; 43(6):621-2. PubMed ID: 20080083
[TBL] [Abstract][Full Text] [Related]
53. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
[TBL] [Abstract][Full Text] [Related]
54. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
Can M; Guven B; Atmaca H; Acıkgoz S; Mungan G
Kaohsiung J Med Sci; 2011 May; 27(5):173-6. PubMed ID: 21527183
[TBL] [Abstract][Full Text] [Related]
55. Variations in prolactin secretion in hyper- and normoprolactinaemia with or without galactorrhoea.
Godo G; Koloszar S; Daru J; Falkay G; Sas M
Acta Med Hung; 1989; 46(1):43-51. PubMed ID: 2771583
[TBL] [Abstract][Full Text] [Related]
56. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
57. [Is the assessment of biological activity of prolactin essential in the diagnosis of hyperprolactinemia?].
Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
Pol Merkur Lekarski; 2010 May; 28(167):359-61. PubMed ID: 20568397
[TBL] [Abstract][Full Text] [Related]
58. Masked hyperprolactinemia: tumor-derived factors inhibiting prolactin secretion caused by pituitary-stalk damage.
Kinoshita Y; Hama S; Tominaga A; Arita K; Sugiyama K; Sakoguchi T; Usui S; Kurisu K
J Clin Neurosci; 2011 Dec; 18(12):1651-5. PubMed ID: 22015098
[TBL] [Abstract][Full Text] [Related]
59. Pre-treatment of serum samples for immunonephelometric analysis by precipitation with polyethylene glycol.
Hellsing K; Enström H
Scand J Clin Lab Invest; 1977 Oct; 37(6):529-36. PubMed ID: 80022
[TBL] [Abstract][Full Text] [Related]
60. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
